THOMAS P SUTULA, MD PHD
Neurology at Highland Ave, Madison, WI
License number
Wisconsin 25808
Category
Neurology
Type
Neurology
License number
Wisconsin 25808
Category
Neurology
Type
Neurology with Special Qualifications in Child Neurology
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 263-5442
(608) 265-1753 (Fax)
(608) 265-1753 (Fax)
Professional information
Dr. Thomas P Sutula, Madison WI - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Neurology, Neuropsychiatry (Neurology)
Address:
UW Health Neurology Clinic
600 Highland Ave STE H6, Madison 53792
(608) 263-5442 (Phone)
600 Highland Ave STE H6, Madison 53792
(608) 263-5442 (Phone)
Certifications:
Internal Medicine, 1978, Neurology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UW Health Neurology Clinic
600 Highland Ave STE H6, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
600 Highland Ave STE H6, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
University Of Pennsylvania School Of Medicine
Graduated: 1975
University Of Va Med Center
University Of Pennsylvania School Of Medicine
Graduated: 1975
University Of Va Med Center
Thomas Peter Sutula, Madison WI
Specialties:
Internal Medicine, Neurology
Work:
University of Wisconsin at Madison
600 Highland Ave, Madison, WI 53792
600 Highland Ave, Madison, WI 53792
Education:
University of Pennsylvania(1975)
Professor At University Of Wisconsin-Madison
Location:
Madison, Wisconsin Area
Industry:
Higher Education
Thomas Sutula
Location:
Madison, Wisconsin Area
Industry:
Biotechnology
Diagnostic And Prognostic Methods And Compositions For Seizure- And Plasticity-Related Disorders
US Patent:
2005012, Jun 9, 2005
Filed:
Nov 5, 2004
Appl. No.:
10/981938
Inventors:
Thomas Sutula - Madison WI, US
Sohail Qureshi - Karachi, PK
Sohail Qureshi - Karachi, PK
International Classification:
C12Q001/68, G01N033/53, G01N033/567, C07H021/04, C07K016/40
US Classification:
435006000, 435007200, 530388100, 536023200
Abstract:
A number of molecules, including genes, gene fragments and encoded gene products which play key roles in function and outcome after initial neuronal injury are disclosed. The disclosed molecules include genes with an association with neural plasticity. The disclosed molecules, as well as the expression patterns associated with these molecules as a group, are used to advantage in a variety of assays for the identification of therapeutic agents to treat epilepsy and other conditions that also involve plasticity of neural circuits, such as stroke, trauma and neurodegenerative diseases. Compositions comprising the disclosed molecules and diagnostic methods, prognostic agents, and test kits in connection with such conditions are also disclosed.
Metabolic-Based Methods For Modulating Gene Expression
US Patent:
2006020, Sep 14, 2006
Filed:
Feb 14, 2006
Appl. No.:
11/353368
Inventors:
Avtar Roopra - Madison WI, US
Thomas Sutula - Madison WI, US
Barry Schoenike - Belleville WI, US
Thomas Sutula - Madison WI, US
Barry Schoenike - Belleville WI, US
International Classification:
A61K 38/17, A61K 31/35, A61K 31/70, A61K 31/19
US Classification:
514012000, 514023000, 514460000, 514557000
Abstract:
This invention provides methods for modulating cellular gene expression for genes operably linked to an NRSE element that is recognized by an NRSF transcriptional repressor, by changing the concentration of reduced nicotinamide adenine dinucleotide (NADH) in the cell.
Neuroprotective Effects Of 2Dg In Traumatic Brain Injury
US Patent:
8633165, Jan 21, 2014
Filed:
Aug 4, 2011
Appl. No.:
13/198376
Inventors:
Elizabeth Brooke Hutchinson - Middleton WI, US
Mary Elizabeth Meyerand - Cross Plains WI, US
Paul Anthony Rutecki - Madison WI, US
Thomas Peter Sutula - Madison WI, US
Mary Elizabeth Meyerand - Cross Plains WI, US
Paul Anthony Rutecki - Madison WI, US
Thomas Peter Sutula - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31/7004
US Classification:
514 23
Abstract:
This invention provides methods for reducing the extent and progression of traumatic brain injury and its deleterious sequellae specifically cognitive decline, post-traumatic epilepsy, post-traumatic stress disorder, and other adverse consequences depending on the progression of the initial injury, comprising administering to a TBI victim in need thereof a therapeutically-effective amount of an antiglycolytic compound, particularly 2-deoxyglucose (2-DG) or glycolysis-inhibiting analogs thereof. The invention also provides pharmaceutical compositions of 2-DG or glycolysis-inhibiting analogs thereof for use in the methods of the invention.
Compounds And Methods For Treating Seizure Disorders
US Patent:
2006028, Dec 21, 2006
Filed:
May 2, 2006
Appl. No.:
11/416643
Inventors:
Steven Kriegler - Madison WI, US
Avtar Roopra - Madison WI, US
Thomas Sutula - Madison WI, US
Carl Stafstrom - Madison WI, US
Avtar Roopra - Madison WI, US
Thomas Sutula - Madison WI, US
Carl Stafstrom - Madison WI, US
International Classification:
A61K 31/70, A61K 31/35
US Classification:
514023000, 514460000
Abstract:
This invention provides methods for alleviating paroxysmal disorders in an animal, particularly epilepsy, by modulating glycolysis in brain cells.
Compounds And Methods For Treating Seizure Disorders
US Patent:
7795227, Sep 14, 2010
Filed:
Jun 17, 2005
Appl. No.:
11/155200
Inventors:
Steven M. Kriegler - Madison WI, US
Avtar S. Roopra - Madison WI, US
Thomas P. Sutula - Madison WI, US
Carl E. Stafstrom - Madison WI, US
Avtar S. Roopra - Madison WI, US
Thomas P. Sutula - Madison WI, US
Carl E. Stafstrom - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31/70
US Classification:
514 23
Abstract:
This invention provides methods for alleviating paroxysmal disorders in an animal, particularly epilepsy, by modulating glycolysis in brain cells.